Neben K - Search Results

1

Combination therapy of Thalidomide and Peginterferon in patients with progressive multiple myeloma.

Kasper B, Moehler T, Neben K, Ho AD, Goldschmidt H. Kasper B, et al. Among authors: neben k. Ann Oncol. 2004 Jan;15(1):176-7. doi: 10.1093/annonc/mdh030. Ann Oncol. 2004. PMID: 14679142 Free article. No abstract available.

2

Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma.

Neben K, Mytilineos J, Moehler TM, Preiss A, Kraemer A, Ho AD, Opelz G, Goldschmidt H. Neben K, et al. Blood. 2002 Sep 15;100(6):2263-5. Blood. 2002. PMID: 12200397 Free article. Clinical Trial.

3

Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide.

Witzens M, Moehler T, Neben K, Fruehauf S, Hartschuh W, Ho AD, Goldschmidt H. Witzens M, et al. Among authors: neben k. Ann Hematol. 2004 Jul;83(7):467-70. doi: 10.1007/s00277-003-0804-0. Epub 2003 Nov 19. Ann Hematol. 2004. PMID: 14625789

4

Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma.

Hillengass J, Fechtner K, Weber MA, Bäuerle T, Ayyaz S, Heiss C, Hielscher T, Moehler TM, Egerer G, Neben K, Ho AD, Kauczor HU, Delorme S, Goldschmidt H. Hillengass J, et al. Among authors: neben k. J Clin Oncol. 2010 Mar 20;28(9):1606-10. doi: 10.1200/JCO.2009.25.5356. Epub 2010 Feb 22. J Clin Oncol. 2010. PMID: 20177023

5

Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment.

Klein U, Neben K, Hielscher T, Heiss C, Ho AD, Goldschmidt H. Klein U, et al. Among authors: neben k. Ann Hematol. 2011 Apr;90(4):429-39. doi: 10.1007/s00277-010-1080-4. Epub 2010 Sep 21. Ann Hematol. 2011. PMID: 20857112

6

[Functional magnetic resonance tomography in the diagnosis and therapy monitoring in multiple myeloma].

Moehler TM, Hawighorst H, Neben K, Egerer G, Benner A, Hillengass J, Max R, Ho AD, Goldschmidt H, van Kaick G. Moehler TM, et al. Among authors: neben k. Radiologe. 2000 Aug;40(8):723-30. doi: 10.1007/s001170050802. Radiologe. 2000. PMID: 11006943 Clinical Trial. German.

7

High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma.

Neben K, Moehler T, Egerer G, Kraemer A, Hillengass J, Benner A, Ho AD, Goldschmidt H. Neben K, et al. Clin Cancer Res. 2001 Sep;7(9):2675-81. Clin Cancer Res. 2001. PMID: 11555579 Clinical Trial.

8

Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion.

Neben K, Moehler T, Kraemer A, Benner A, Egerer G, Ho AD, Goldschmidt H. Neben K, et al. Br J Haematol. 2001 Dec;115(3):605-8. doi: 10.1046/j.1365-2141.2001.03142.x. Br J Haematol. 2001. PMID: 11736942 Free article. Clinical Trial.

9

Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy.

Moehler TM, Neben K, Benner A, Egerer G, Krasniqi F, Ho AD, Goldschmidt H. Moehler TM, et al. Among authors: neben k. Blood. 2001 Dec 15;98(13):3846-8. doi: 10.1182/blood.v98.13.3846. Blood. 2001. PMID: 11739195 Free article.

10

Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents.

Merz M, Neben K, Raab MS, Sauer S, Egerer G, Hundemer M, Hose D, Kunz C, Heiß C, Ho AD, Goldschmidt H, Hillengass J. Merz M, et al. Among authors: neben k. Ann Oncol. 2014 Jan;25(1):189-95. doi: 10.1093/annonc/mdt509. Ann Oncol. 2014. PMID: 24356629 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters